Grant Pickering is the founder of Vaxcyte. Vaxcyte has raised $2.4B in total funding. Latest round: IPO. Based in South San Francisco, United States.
Grant Pickering is the Co-Founder, CEO, and Director of Vaxcyte, a clinical-stage vaccine innovation company based in San Carlos, California. The company focuses on re-engineering vaccine production using advanced chemistry and modern synthetic techniques, including a cell-free protein synthesis platform, to develop vaccines for infectious diseases such as pneumococcal disease, Group A Strep, and Shigella. Prior to founding Vaxcyte in 2013, Pickering was the CEO of Mymetics Corporation, a European-based vaccine company, and an executive-in-residence at Kleiner, Perkins, Caufield & Byers.
Full founder directory · Investor directory · Company funding database · Fundraising library